Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 1/20 | 0.42 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.41 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.41 |
| ▸ | NAAA | Q02083 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | LCK | P06239 | 1/20 | 0.39 |
| ▸ | PPARD | Q03181 | 1/20 | 0.39 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.39 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27692872 | 0.98 | HTR2A (0.45) | SIGMAR1HTR2ACSNK1EOPRM1OPRD1 | |
| SCHEMBL27806681 | 0.98 | HTR2A (0.45) | SIGMAR1HTR2ACSNK1EOPRM1OPRD1 | |
| SCHEMBL11806604 | 0.98 | HTR2A (0.45) | SIGMAR1HTR2ACSNK1EOPRM1OPRD1 | |
| SCHEMBL6681848 | 0.98 | HTR2A (0.45) | SIGMAR1HTR2ACSNK1EOPRM1OPRD1 | |
| SCHEMBL6685358 | 0.98 | HTR2A (0.45) | SIGMAR1HTR2ACSNK1EOPRM1OPRD1 | |
| SCHEMBL8728015 | 0.98 | HTR2A (0.45) | SIGMAR1HTR2ACSNK1EOPRM1OPRD1 | |
| SCHEMBL14636124 | 0.98 | HTR2A (0.45) | SIGMAR1HTR2ACSNK1EOPRM1OPRD1 | |
| SCHEMBL7573099 | 0.98 | HTR2A (0.45) | SIGMAR1HTR2ACSNK1EOPRM1OPRD1 | |
| SCHEMBL22734895 | 0.98 | HTR2A (0.45) | SIGMAR1HTR2ACSNK1EOPRM1OPRD1 | |
| SCHEMBL2404354 | 0.98 | HTR2A (0.45) | SIGMAR1HTR2ACSNK1EOPRM1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117447459-A | Method for synthesizing rotigorskite key intermediate by using chiral phase transfer catalyst as catalyst | 瑞博(杭州)医药科技有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-112960656-A | Preparation method of vanadium nitride nanoparticle composite material for lithium-sulfur battery | 福建师范大学 | 2021-06-15 | — | — | CN | claimed |
| CN-109232520-A | 5,5 '-two (styryl) -3,3 '-union II thiophene derivants, synthetic method and its application | 上海应用技术大学 | 2019-01-18 | — | — | CN | claimed |
| CN-109232519-A | 4,4 '-two (styryl) -3,3 '-union II thiophene derivants, synthetic method and its application | 上海应用技术大学 | 2019-01-18 | — | — | CN | claimed |
| CN-106749318-B | A kind of organic field effect tube material and its synthetic method and application based on oxa- condensed ring class | 苏州大学 | 2019-01-08 | — | — | CN | claimed |
| CN-106349287-B | Quaternary phosphonium salt class compound with piezallochromy property and its preparation method and application | 四川大学 | 2018-12-21 | — | — | CN | claimed |
| CN-105820151-B | 2,2 '-di (styryl) -3, 3' -bithiophene derivative, synthetic method and application thereof | 上海应用技术学院 | 2018-05-01 | — | — | CN | claimed |
| CN-106397100-A | Synthesis method of amorolfine drug intermediate p-tertiary amyl benzyl bromide | 厦门市凯尔利信息科技有限公司 | 2017-02-15 | — | — | CN | claimed |
| CN-106349287-A | Quaternary phosphonium salts compound with piezochromism property and preparation method and application of quaternary phosphonium salts compound | 四川大学 | 2017-01-25 | — | — | CN | claimed |
| CN-105820151-A | 2,2 '-di (styryl) -3, 3' -bithiophene derivative, synthetic method and application thereof | 上海应用技术学院 | 2016-08-03 | — | — | CN | claimed |
| US-12607789-B2 | Display panel and method of manufacturing the same and electronic device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2026-04-21 | — | — | US | disclosed |
| US-20250311610-A1 | COPOLYMER, AND COMPOSITION, LIQUID COMPOSITION, AND ELECTROLUMINSECNT DEVICE INCLUDING THE COPOLYMER | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-10-02 | — | — | US | disclosed |
| EP-4624510-A1 | COPOLYMER, COMPOSITION, LIQUID COMPOSITION, AND ELECTROLUMINSECNT DEVICE INCLUDING THE COPOLYMER | Samsung Electronics Co., Ltd. (KR) | 2025-10-01 | — | — | EP | disclosed |
| CN-115850002-B | Method for hydrodehalogenating halogenated alkane | 中国科学院兰州化学物理研究所 | 2025-05-23 | — | — | CN | disclosed |
| CN-118076663-A | Composition and ink composition | 住友化学株式会社 | 2024-05-24 | — | — | CN | disclosed |
| EP-0985649-B1 | Method for producing an aromatic compound having an alkyl group with at least three carbon atoms | TORAY INDUSTRIES (JP) | 2004-11-24 | — | — | EP | disclosed |
| US-6462248-B1 | THROUGH CONVERSION, ISOMERIZATION AND/OR ADSORPTIVE SEPARATION OF AROMATIC COMPOUNDS | TORAY INDUSTRIES, INC. (JP) | 2002-10-08 | — | — | US | disclosed |
| EP-0985649-A2 | Method for producing an aromatic compound having an alkyl group with at least three carbon atoms | TORAY INDUSTRIES, INC. (JP) | 2000-03-15 | — | — | EP | disclosed |
| EP-0905172-A1 | POLYSILANES AND POSITIVE HOLE TRANSPORTING MATERIALS | OSAKA GAS CO., LTD. (JP) | 1999-03-31 | — | — | EP | disclosed |
| WO-1997010247-A1 | CLAVULANIC ACID DERIVATIVES FOR TREATING ATHEROSCLEROSIS | SMITHKLINE BEECHAM P.L.C. (GB) | 1997-03-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12607789-B2 | Display panel and method of manufacturing the same and electronic device | CD63, CD2, NECTIN4 | SIGMAR1 2867/4885HTR2A 1356/4885CSNK1E 1880/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.